Tower Research Capital (TRC)’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91K | Buy |
3,688
+2,968
| +412% | +$3.15K | ﹤0.01% | 4412 |
|
|
2025
Q1 | $785 | Sell |
720
-805
| -53% | -$878 | ﹤0.01% | 4831 |
|
|
2024
Q4 | $2.3K | Sell |
1,525
-662
| -30% | -$999 | ﹤0.01% | 4866 |
|
|
2024
Q3 | $3.26K | Sell |
2,187
-12,709
| -85% | -$18.9K | ﹤0.01% | 4874 |
|
|
2024
Q2 | $24.1K | Buy |
14,896
+10,250
| +221% | +$16.6K | ﹤0.01% | 3653 |
|
|
2024
Q1 | $7.9K | Sell |
4,646
-4,862
| -51% | -$8.27K | ﹤0.01% | 4117 |
|
|
2023
Q4 | $29.5K | Buy |
9,508
+7,368
| +344% | +$22.8K | ﹤0.01% | 3436 |
|
|
2023
Q3 | $13.1K | Buy |
2,140
+1,165
| +119% | +$7.15K | ﹤0.01% | 3825 |
|
|
2023
Q2 | $6.1K | Sell |
975
-813
| -45% | -$5.09K | ﹤0.01% | 4715 |
|
|
2023
Q1 | $9K | Sell |
1,788
-10,304
| -85% | -$51.9K | ﹤0.01% | 4528 |
|
|
2022
Q4 | $105K | Sell |
12,092
-12,602
| -51% | -$109K | ﹤0.01% | 1801 |
|
|
2022
Q3 | $294K | Buy |
24,694
+10,592
| +75% | +$126K | ﹤0.01% | 1568 |
|
|
2022
Q2 | $201K | Buy |
14,102
+13,017
| +1,200% | +$186K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $23K | Sell |
1,085
-8,595
| -89% | -$182K | ﹤0.01% | 3400 |
|
|
2021
Q4 | $224K | Buy |
9,680
+6,142
| +174% | +$142K | ﹤0.01% | 1673 |
|
|
2021
Q3 | $105K | Buy |
3,538
+2,503
| +242% | +$74.3K | ﹤0.01% | 2361 |
|
|
2021
Q2 | $35K | Sell |
1,035
-1,737
| -63% | -$58.7K | ﹤0.01% | 3329 |
|
|
2021
Q1 | $91K | Buy |
2,772
+2,333
| +531% | +$76.6K | ﹤0.01% | 2659 |
|
|
2020
Q4 | $27K | Buy |
+439
| New | +$27K | ﹤0.01% | 3665 |
|